Founder, CEO, Managing Director

nathan@netadiscovery.org

My fascination for neuroscience has been present for some time with a family member with KBG syndrome and myself having a lived experience with Epilepsy. This led to a recent PhD journey in studying transcriptomic data to better understand mechanisms of Epilepsy. With my developed understanding of bioinformatics as a result of long nights of computing code to unlock biological pathways, I realized a lot more could be done and needed to be done post PhD. So, with this initial journey and being an Epilepsy advocate I have founded Neuronal Epileptotranscriptomic Advancement (NETA).

Research Director

With an extensive background in molecular biology and genetics, coupled with a growing interest in bioinformatics, I have spent over a decade investigating cancer, drug discovery, cardiovascular, lymphatics, and brain function using zebrafish as a model organism. Building on these diverse experiences, I am now focused on integrating these insights to understand and advance the development of personalized treatment strategies.

Director 

I am an emerging and passionate scientist specializing in Precision Medicine, Neuroscience, and Translational Science, with expertise in Genetics and Molecular Research, focusing on the role of polymorphisms and haplotypes in neuroinflammation, Alzheimer’s disease (AD), Parkinson’s disease (PD), and longevity-related mechanisms. At Full DNA (Transceptar Technologies), I utilized Illumina’s GSA v3.0 microarray to analyse ~700,000 SNPs in Southeast Asian cohorts, generating genomic datasets and developed a novel SNP-driven metabolic pathway linked to disease progression with epigenetics-based solutions.  

 My neuroscience research at RMIT University, Australia, revolved around neonatal stroke (NS) and brain injury, employing a photothrombotic stroke model and immunohistochemistry (IHC) to visualize lesions and behavioural analysis in mice models to identify therapeutic targets for motor impairment. I hold an MSc in Biotechnology and a BSc in Biomedical Sciences (Medical) from Australia, a Genetics & Genomics specialization program from Stanford University, and I am currently advancing my expertise in AI/ML-driven analysis through a Data Science program at IITK. Beyond research, I advocate for scientific literacy and personalized medicine, presenting at international conferences such as SLiSS 2024 (Malaysia), and received the Leadership in Communities Award (LiCA) from the University of Melbourne for my contributions to community services.